Interestingly, among the identified drugs, we found that the anti-proliferative effects of cardiac glycosides ouabain and digoxin are more pronounced in ERα-positive BC cell lines compared to ERα-negative ones, primarily due to their ability to induce ERα degradation9,13. This evidence concerns the gene ESR1 and breast cancer.